Gossamer Bio, Inc.
GOSS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $13,294 | $11,489 | $9,889 | $9,379 |
| % Growth | 15.7% | 16.2% | 5.4% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $13,294 | $11,489 | $9,889 | $9,379 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $53,018 | $41,575 | $38,041 | $36,112 |
| G&A Expenses | $9,390 | $8,679 | $8,658 | $9,395 |
| SG&A Expenses | $9,390 | $8,679 | $8,658 | $9,395 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $62,408 | $50,254 | $46,699 | $45,507 |
| Operating Income | -$49,114 | -$38,765 | -$36,810 | -$36,128 |
| % Margin | -369.4% | -337.4% | -372.2% | -385.2% |
| Other Income/Exp. Net | $893 | $492 | $172 | $689 |
| Pre-Tax Income | -$48,221 | -$38,273 | -$36,638 | -$35,439 |
| Tax Expense | $0 | $0 | $0 | -$2,410 |
| Net Income | -$48,221 | -$38,273 | -$36,638 | -$33,029 |
| % Margin | -362.7% | -333.1% | -370.5% | -352.2% |
| EPS | -0.21 | -0.17 | -0.16 | -0.15 |
| % Growth | -23.5% | -6.3% | -6.7% | – |
| EPS Diluted | -0.21 | -0.17 | -0.16 | -0.15 |
| Weighted Avg Shares Out | 227,981 | 227,275 | 226,818 | 226,604 |
| Weighted Avg Shares Out Dil | 227,981 | 227,275 | 226,818 | 226,604 |
| Supplemental Information | – | – | – | – |
| Interest Income | $687 | $542 | $294 | $0 |
| Interest Expense | $2,748 | $2,744 | $2,746 | $2,738 |
| Depreciation & Amortization | $6 | $213 | $342 | $1,075 |
| EBITDA | -$45,467 | -$35,316 | -$33,550 | -$31,626 |
| % Margin | -342% | -307.4% | -339.3% | -337.2% |